🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT07279740
Recruiting Phase 2

Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia

NCT07279740 · tracked via the Priya Life Science Canada tracker
Phase
Phase 2
Started
2026-01
Last updated
2025-12-12

Condition(s) studied

Alzheimer s DiseaseAlzheimer Dementia (AD)Alzheimer DementiaAlzheimer DiseaseApathyApathy in Dementia

Investigational drug(s) / intervention(s)

intermittent theta burst stimulation (iTBS)Methylphenidate (MPH) →

intermittent theta burst stimulation (iTBS): iTBS is a form of repetitive transcranial magnetic simulation (rTMS), a non-invasive form of brain stimulation.

Methylphenidate (MPH): Participants will be on methylphenidate clinically prior to the trial

Study summary

This study evaluates whether the combined treatment of methylphenidate and non-invasive brain stimulation, called intermittent theta burst stimulation, can effectively treat apathy in individuals with Alzheimer's disease or mixed AD/vascular dementia

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Alzheimer's disease or mixed Alzheimer's disease and vascular disease * MMSE score 10-28 inclusive * Clinically significant apathy * Stable dose of psychotropic medication * Care partner must spend at least 10hrs/week with the participant Exclusion Criteria: * Major Depressive Episode * Clinically significant agitation, delusions, hallucinations * Currently talking a dopaminergic agent other than methylphenidate * Failure to clear the TMS adult safety scale (e.g. unapproved pacemakers, metallic implants, history of epilepsy) * Central nervous system abnormalities (other than Alzheimer's disease) deemed clinically significant by study physician or seizures * Any condition that in the opinion of the study physician, makes it medically unsafe for the patient to enroll in the trial

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sunnybrook Research Institute Toronto Ontario Recruiting

More Sunnybrook Health Sciences Centre trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07279740 on ClinicalTrials.gov ↗ ← All trials in Canada